US

Ushmaben Snehal Patel

Active Director Director DIN 08327717
DIN 08327717 First appointment Jan 2019 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ushmaben Snehal Patel

Data last updated:

Ushmaben Snehal Patel is a Director at Dictum Medical Management Private Limited (since 2019). The company operates in Information Technology.

DIN 08327717
Primary Designation Director
Industry Information Technology
First Appointment 10 Jan 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jan 20192018Active

Board colleagues of Ushmaben Snehal Patel

NameDINCompanyDesignation
Ravi Arya06622542Dictum Medical Management Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dictum Medical Management Private Limited
Premium access

Shareholding and investment profile for Ushmaben Snehal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ushmaben Snehal Patel

Ushmaben Snehal Patel currently holds 1 directorship: Dictum Medical Management Private Limited (Director, since 10 Jan 2019).

Ushmaben Snehal Patel was first appointed on 10 Jan 2019 as Director at Dictum Medical Management Private Limited.

The current boards of Ushmaben Snehal Patel's companies include Ravi Arya (Dictum Medical Management Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available